Indication
Muscle spasticity of cerebral origin
Muscle spasticity of cerebral origin is a chronic motor impairment within upper motor neuron syndrome, resulting specifically from injury or pathology localized to the brain rather than the spinal cord. Read more about Muscle spasticity of cerebral origin
82 drugs 63 manufacturers
Drugs that treat it
Common Muscle spasticity of cerebral origin therapies.
BACLOFEN
TIZANIDINE HCL
DANTROLENE SODIUM
TIZANIDINE HCL
TIZANIDINE HCL
TIZANIDINE HCL
TIZANIDINE HCL
TIZANIDINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMuscle spasticity of cerebral origin is a chronic motor impairment within upper motor neuron syndrome, resulting specifically from injury or pathology localized to the brain rather than the spinal cord.
It commonly affects pediatric and adult populations with cerebral palsy, traumatic brain injury, ischemic or hemorrhagic stroke, or hypoxic-ischemic encephalopathy.
Pathophysiologically, disruption of descending corticospinal and reticulospinal inhibitory pathways causes disinhibition and hyper-excitability of spinal stretch reflex arcs.
Clinically, it is characterized by a velocity-dependent increase in tonic stretch reflexes and muscle resistance to passive movement, often accompanied by clonus, involuntary spasms, impaired voluntary motor control, and increased risk of joint contractures.
- nih.gov
Muscle spasticity of cerebral origin is a chronic motor impairment within upper motor neuron syndrome, resulting specifically from injury or pathology localized to the brain rather than the spinal cord It commonly affects pediatric and adult populations with cerebral palsy, traumatic brain injury, ischemic or hemorrhagic stroke, or hypoxic-ischemic encephalopathy
- nih.gov
Muscle spasticity of cerebral origin is a chronic motor impairment within upper motor neuron syndrome, resulting specifically from injury or pathology localized to the brain rather than the spinal cord Pathophysiologically, disruption of descending corticospinal and reticulospinal inhibitory pathways causes disinhibition and hyper-excitability of spinal stretch reflex arcs Clinically, it is characterized by a velocity-dependent increase in tonic stretch reflexes and muscle resistance to passive ...
- nih.gov
It commonly affects pediatric and adult populations with cerebral palsy, traumatic brain injury, ischemic or hemorrhagic stroke, or hypoxic-ischemic encephalopathy Clinically, it is characterized by a velocity-dependent increase in tonic stretch reflexes and muscle resistance to passive movement, often accompanied by clonus, involuntary spasms, impaired voluntary motor control, and increased risk of joint contractures
- aans.org
Pathophysiologically, disruption of descending corticospinal and reticulospinal inhibitory pathways causes disinhibition and hyper-excitability of spinal stretch reflex arcs
- chop.edu
Clinically, it is characterized by a velocity-dependent increase in tonic stretch reflexes and muscle resistance to passive movement, often accompanied by clonus, involuntary spasms, impaired voluntary motor control, and increased risk of joint contractures
Personalize your experience
Follow Muscle spasticity of cerebral origin and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.